Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells
about
Grb10 prevents Nedd4-mediated vascular endothelial growth factor receptor-2 degradationScatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisMet kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survivalActivation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells.Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells.Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study.Involvement of protein kinase CK2 in angiogenesis and retinal neovascularizationAssociations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity.Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeEffect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16.The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.Endocan: A new marker for cancer and a target for cancer therapy.Tissue-Specific Gain of RTK Signalling Uncovers Selective Cell Vulnerability during Embryogenesis.Human umbilical cord blood plasma can replace fetal bovine serum for in vitro expansion of functional human endothelial colony-forming cells.Grb10 and Grb14: enigmatic regulators of insulin action--and more?A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancerSignaling and functions of angiopoietin-1 in vascular protection.Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinomaExpression of interleukin-17RC protein in normal human tissuesEndocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.Successful use of platelet-rich plasma for chronic plantar fasciitisLoss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expressionThe dual-specificity MAP kinase phosphatases: critical roles in development and cancer.VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications.VEGF-A and serum withdrawal induced changes in the transcript profile in human endometrial endothelial cells.qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development.Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan.Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.The modulation of endothelial cell gene expression by green tea polyphenol-EGCG.Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects.Knockdown of stromal interaction molecule 1 attenuates hepatocyte growth factor-induced endothelial progenitor cell proliferation.Prognostic significance of c-Met expression in glioblastomas.Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma.Topical transplantation of mesenchymal stem cells accelerates gastric ulcer healing in rats.Transcriptome of angiopoietin 1-activated human umbilical vein endothelial cells.Endocan silencing induces programmed cell death in hepatocarcinoma.Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma.
P2860
Q24323121-FAD293F6-8BFB-4909-AA84-3D4B98EE43E8Q24683896-1A289F91-B4D4-4ECA-9768-BA06825677C0Q27316936-9D643A5C-EB61-4B63-B86E-C2932368C122Q33511579-072BC693-8011-4080-8B8C-7FF634379208Q33675494-C162251F-5253-4678-B5E5-2F05E3409ADAQ33990421-88BDC674-3F7E-4F57-B4F5-51E846AFB5EFQ34027810-35AC8FE9-70F5-400B-B322-95899397D390Q34049304-29166B2D-2DE3-4F0D-84BA-BAF3579BBD9CQ34456779-AB5847B2-0D25-4734-B32C-630AAA308E81Q34576344-0F5F1CD2-EB1A-43B2-9B21-8F12078CF3DEQ34619635-5E5C7CC3-4A5E-4AC7-9DFE-BFC2CB68F8A2Q34657623-B3CB1057-F758-4E76-B8A7-C9B0FEB804D0Q35563524-D2E9817E-0538-4CEE-82E2-0ECC3168087BQ35681482-9EC858C2-06BD-413A-BAE8-B19DD0108DE5Q35783030-61C56218-0470-426B-92AD-69B3EA1DABDEQ36071299-7BAF6984-47BF-4EDB-A150-BD34ECEE1CE6Q36131371-DE88B6A3-D3E3-4DE2-BA56-42D126F9B0D2Q36333585-4E5852D6-E615-4069-85EE-5B2A433A417AQ36462707-D7E8017F-369A-4A89-8ACD-183FCE31251EQ36710395-52024754-383A-42E4-A739-BF6EA7395CC2Q36999576-9937D177-8BC9-4D59-B9D1-44B04AF4FD87Q37012393-EFECF224-6308-4C53-8CB6-39C0B64247AAQ37132917-75372CB0-5067-42F2-ADC7-FC3C42C1BEA6Q37706719-9239F5A6-CA58-4929-8AE4-3CEFDD69B8CBQ37750129-3D8FFE5A-14CE-452B-8327-388AFE966D68Q37848687-ABBDDF4B-4614-40F5-9D4F-18D06D136E36Q38506904-091605D7-CA5E-4769-A037-BEC63A917812Q38941700-8C3D18AD-63BF-4F3E-A98F-261C07F2AA0CQ39431959-34CF58F8-7A63-402E-BDEF-5F3BF93520BEQ40374481-B5F873A2-12A8-46B9-B4BB-A6ED1ACD8F14Q41769428-3E367CE8-C02A-466A-A6D4-8F612D6F4048Q41791347-93B248FA-89BC-4C48-8D67-CFD6595E7538Q41891314-639A414F-A415-43BC-8000-F5974F0FCF43Q43093134-88E118C8-3F3E-4A68-BEBD-44C8E70D7016Q46170165-E8197FB3-31A0-4F01-B96F-A280F6EEBB94Q46568714-826A1CD4-9C05-413C-BB83-76CAEDFD3EC2Q46803359-D8632224-B020-43F0-8750-4F35ABDD7912Q46849813-2685F7F9-232A-4D21-AA34-0759C327C3AAQ47139612-04396FF1-86ED-4012-B9C7-E2F09B0BC2F3Q47148074-0630297C-08E4-4EE7-A4A0-E2F819E9A115
P2860
Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Using gene expression profilin ...... tor in human endothelial cells
@ast
Using gene expression profilin ...... tor in human endothelial cells
@en
Using gene expression profilin ...... tor in human endothelial cells
@nl
type
label
Using gene expression profilin ...... tor in human endothelial cells
@ast
Using gene expression profilin ...... tor in human endothelial cells
@en
Using gene expression profilin ...... tor in human endothelial cells
@nl
prefLabel
Using gene expression profilin ...... tor in human endothelial cells
@ast
Using gene expression profilin ...... tor in human endothelial cells
@en
Using gene expression profilin ...... tor in human endothelial cells
@nl
P2093
P2860
P356
P1476
Using gene expression profilin ...... tor in human endothelial cells
@en
P2093
Constance Zlot
James E Tomlinson
Mary E Gerritsen
Michael Ziman
Stuart Hwang
P2860
P304
P356
10.1038/SJ.BJP.0705494
P407
P577
2003-10-01T00:00:00Z